These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29643934)

  • 1. Extra-telomeric functions of telomerase in the pathogenesis of Epstein-Barr virus-driven B-cell malignancies and potential therapeutic implications.
    Giunco S; Petrara MR; Zangrossi M; Celeghin A; De Rossi A
    Infect Agent Cancer; 2018; 13():14. PubMed ID: 29643934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.
    Giunco S; Celeghin A; Gianesin K; Dolcetti R; Indraccolo S; De Rossi A
    Cell Death Dis; 2015 May; 6(5):e1774. PubMed ID: 26018735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
    Celeghin A; Giunco S; Freguja R; Zangrossi M; Nalio S; Dolcetti R; De Rossi A
    Cell Death Dis; 2016 Dec; 7(12):e2562. PubMed ID: 28032863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
    Terrin L; Dolcetti R; Corradini I; Indraccolo S; Dal Col J; Bertorelle R; Bonaldi L; Esposito G; De Rossi A
    Int J Cancer; 2007 Aug; 121(3):576-87. PubMed ID: 17417773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and telomerase: from cell immortalization to therapy.
    Dolcetti R; Giunco S; Dal Col J; Celeghin A; Mastorci K; De Rossi A
    Infect Agent Cancer; 2014 Feb; 9(1):8. PubMed ID: 24572088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment.
    Petrara MR; Giunco S; Serraino D; Dolcetti R; De Rossi A
    Cancer Lett; 2015 Dec; 369(1):37-44. PubMed ID: 26279520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death.
    Hui KF; Chiang AK
    Int J Cancer; 2010 May; 126(10):2479-89. PubMed ID: 19816947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
    Liu X; Cohen JI
    J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis.
    Münz C
    Nat Rev Microbiol; 2019 Nov; 17(11):691-700. PubMed ID: 31477887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus.
    Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells.
    Nawandar DM; Wang A; Makielski K; Lee D; Ma S; Barlow E; Reusch J; Jiang R; Wille CK; Greenspan D; Greenspan JS; Mertz JE; Hutt-Fletcher L; Johannsen EC; Lambert PF; Kenney SC
    PLoS Pathog; 2015 Oct; 11(10):e1005195. PubMed ID: 26431332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Proliferative and Pro-Apoptotic Effects of Short-Term Inhibition of Telomerase In Vivo and in Human Malignant B Cells Xenografted in Zebrafish.
    Giunco S; Zangrossi M; Dal Pozzolo F; Celeghin A; Ballin G; Petrara MR; Amin A; Argenton F; Godinho Ferreira M; De Rossi A
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization.
    Kamranvar SA; Masucci MG
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28792435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
    Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Term TERT Inhibition Impairs Cellular Proliferation via a Telomere Length-Independent Mechanism and Can Be Exploited as a Potential Anticancer Approach.
    Amin A; Morello M; Petrara MR; Rizzo B; Argenton F; De Rossi A; Giunco S
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
    Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
    J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development.
    Tornesello ML; Cerasuolo A; Starita N; Tornesello AL; Bonelli P; Tuccillo FM; Buonaguro L; Isaguliants MG; Buonaguro FM
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.
    Kim H; Choi H; Lee SK
    J Virol; 2016 Feb; 90(3):1359-68. PubMed ID: 26581978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.